全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

加味半夏泻心汤联合四联治疗脾胃湿热型幽门螺杆菌相关性慢性胃炎40例临床疗效观察
Observation on the Clinical Efficacy of Added Banxia Xiexin Decoction and Quadruple Drug Therapy in the Treatment of 40 Cases of Chronic Gastritis Associated with Hp-Related Chronic Gastritis with Spleen Stomach Damp

DOI: 10.12677/tcm.2025.141036, PP. 229-234

Keywords: Hp相关性慢性胃炎,幽门螺杆菌,半夏泻心汤,四联疗法
Helicobacter Pylori (Hp)-Related Chronic Gastritis
, Helicobacter Pylori, Banxia Xiexin Decoction, Quadruple Drug Therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:探究加味半夏泻心汤联合四联疗法治疗幽门螺杆菌(Hp)相关性慢性胃炎脾胃湿热型的临床疗效。方法:将2022年7月~2024年7月随州市中医医院脾胃病科科诊治的40例Hp感染后脾胃湿热型慢性胃炎患者作为研究对象,随机将研究对象分为对照组(四联疗法)和研究组(四联疗法合用加味半夏泻心汤),每组各20例。观察两组患者临床症状治疗有效率、Hp根除率及中医证候积分的变化情况。结果:研究组(四联疗法合用加味半夏泻心汤组)证候治疗有效率、Hp根除率均高于对照组(四联疗法组),差异有统计学意义(P < 0.05);研究组(四联疗法合用加味半夏泻心汤组)上述指标均低于对照组(四联疗法组),差异有统计学意义(P < 0.05)。结论:在Hp相关性脾胃湿热型慢性胃炎的治疗中,加味半夏泻心汤联合四联疗法能更好地根除Hp,能快速改善患者相关临床证候,提高其日常生活质量,经济高效,疗效可靠。
Objective: To explore the clinical efficacy of modified Banxia Xiexin Tang combined with quadruple therapy in the treatment of Helicobacter pylori (Hp)-related chronic gastritis with spleen stomach damp heat type. Methods: Forty patients with chronic gastritis of spleen and stomach damp heat type after Hp infection treated by the type of Spleen and Stomach Diseases from July 2022 to July 2024 were selected as the study subjects. The study subjects were randomly divided into a control group (quadruple therapy) and a study group (quadruple therapy combined with modified Banxia Xiexin Tang), with 20 cases in each group. Observe the changes in the effective rate of clinical symptom treatment, Hp eradication rate, and TCM syndrome score between two groups of patients. Results: The treatment efficacy and Hp eradication rate of the research group (the combination of quadruple therapy and modified Banxia Xiexin Tang group) were higher than those in the other one (the quadruple therapy group); The above indicators in the research group (the combination of quadruple therapy and modified Banxia Xiexin Tang group) were lower than those in the other group (quadruple therapy group), the difference was statistically significant (P < 0.05). Conclusion: In the treatment of Hp related spleen stomach damp heat chronic gastritis, the combination of modified Banxia Xiexin Tang and quadruple therapy can better eradicate Hp, rapidly improve patients' relevant clinical symptoms, enhance their quality of life, and have reliable therapeutic effects. It is recommended for application.

References

[1]  刘文忠, 谢勇, 陆红, 等. 第五次全国幽门螺杆菌感染处理共识报告[J]. 中华消化杂志, 2017, 37(6): 1-16.
[2]  王继德, 牛凌云. 胃外幽门螺杆菌的致病性与临床意义[J]. 胃肠病学和肝病学杂志, 2008, 17(7): 532-535.
[3]  宋元彬. 幽门螺杆菌的致病机制及检测方法[J]. 中国医学创新, 2022, 19(34): 184-188.
[4]  独思静, 陶紫晶, 方霜霜, 等. 中西医协作治疗幽门螺杆菌胃炎的思路探讨[J]. 世界中西医结合杂志, 2021, 16(6): 1159-1162.
[5]  白海燕, 郝旭蕊, 李娜, 等. 化浊解毒方治疗慢性萎缩性胃炎伴幽门螺杆菌感染患者的临床研究[J]. 南京中医药大学学报, 2020, 36(3): 326-330.
[6]  周义方, 喻斌. 中西医结合治疗HP相关性胃炎脾胃湿热证Meta分析[J]. 湖南中医杂志, 2019, 35(7): 129-131.
[7]  陈万群, 黄玉兰, 杨小军. 运脾清热除湿方治疗幽门螺杆菌相关性胃炎消化不良的临床观察及可能机制[J]. 湖南中医药大学学报, 2019, 39(5): 635-639.
[8]  Feng, W., Ao, H., Peng, C. and Yan, D. (2019) Gut Microbiota, a New Frontier to Understand Traditional Chinese Medicines. Pharmacological Research, 142, 176-191.
https://doi.org/10.1016/j.phrs.2019.02.024
[9]  王萍, 卞立群, 杨倩, 等. 慢性胃炎中医诊疗专家共识(2023) [J]. 中华中医药杂志, 2023, 38(12): 5904-5911.
[10]  高云云, 刘文文, 尹志鹏, 等. 半夏泻心汤治疗幽门螺杆菌相关性胃炎作用机制的网络药理学分析[J]. 中国病原生物学杂志, 2021, 16(8): 871-877.
[11]  刘令令, 段飞, 杜巧婷, 等. 加减半夏泻心汤治疗幽门螺杆菌相关性胃炎的作用机制[J]. 中医学报, 2022, 37(3): 599-608.
[12]  贾献玲, 王海霞, 邹佳辰, 等. 加味半夏泻心汤拆方对幽门螺旋杆菌相关性胃炎小鼠的作用及机制研究[J]. 海南医学院学报, 2024, 30(16): 1210-1219.
[13]  杨文君, 王晶, 刘二委. 加味半夏泻心汤对幽门螺杆菌相关性胃炎(脾胃湿热型)患者胃黏膜状态、细胞毒素相关蛋白A及空泡毒素A水平的影响[J]. 湖北中医杂志, 2023, 45(3): 36-38.
[14]  张亚峰, 冯秉涛, 郭丽. 半夏泻心汤加减方辅助治疗根除幽门螺杆菌失败的慢性胃炎(寒热错杂型)患者的效果及其对血清胃蛋白酶原水平的影响[J]. 辽宁医学杂志, 2022, 36(1): 47-50.
[15]  房静远, 杜奕奇, 刘文忠, 任建林, 李延青, 陈晓宇, 吕农华, 陈萦晅, 吕宾. 中国慢性胃炎共识意见精简版(2017年, 上海) [J]. 上海医学, 2017, 40(12): 705-708.
[16]  郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002.
[17]  中华中医药学会脾胃病分会, 唐旭东, 杨倩. 慢性胃炎中医诊疗专家共识(2023) [J]. 中华中医药杂志, 2023, 38(12): 5904-5911.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133